These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22917880)

  • 1. Central administration of oxytocin reduces hyperalgesia in mice: implication for cannabinoid and opioid systems.
    Russo R; D'Agostino G; Mattace Raso G; Avagliano C; Cristiano C; Meli R; Calignano A
    Peptides; 2012 Nov; 38(1):81-8. PubMed ID: 22917880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model.
    Stepanović-Petrović RM; Micov AM; Tomić MA; Ugrešić ND
    Anesth Analg; 2012 Dec; 115(6):1457-66. PubMed ID: 23144430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
    Schiene K; De Vry J; Tzschentke TM
    J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Euphol, a tetracyclic triterpene produces antinociceptive effects in inflammatory and neuropathic pain: the involvement of cannabinoid system.
    Dutra RC; Simão da Silva KA; Bento AF; Marcon R; Paszcuk AF; Meotti FC; Pianowski LF; Calixto JB
    Neuropharmacology; 2012 Sep; 63(4):593-605. PubMed ID: 22613837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin inhibits inflammatory pain in rats: involvement of the opioid system.
    Sibilia V; Lattuada N; Rapetti D; Pagani F; Vincenza D; Bulgarelli I; Locatelli V; Guidobono F; Netti C
    Neuropharmacology; 2006 Sep; 51(3):497-505. PubMed ID: 16759671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects.
    De Vry J; Denzer D; Reissmueller E; Eijckenboom M; Heil M; Meier H; Mauler F
    J Pharmacol Exp Ther; 2004 Aug; 310(2):620-32. PubMed ID: 15140913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-terminally extended hemopressin peptide.
    Han ZL; Fang Q; Wang ZL; Li XH; Li N; Chang XM; Pan JX; Tang HZ; Wang R
    J Pharmacol Exp Ther; 2014 Feb; 348(2):316-23. PubMed ID: 24307201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypersensitivity effects of tramadol hydrochloride in a rat model of postoperative pain.
    Kimura M; Obata H; Saito S
    Anesth Analg; 2012 Aug; 115(2):443-9. PubMed ID: 22575568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioidergic mechanisms are not involved in the antihyperalgesic effects of carbamazepine and oxcarbazepine.
    Stepanovic-Petrovic RM; Tomic MA; Vuckovic SM; Ugresic ND; Prostran MS; Boskovic B
    Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):191-4. PubMed ID: 17520100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanisms of antihyperalgesic effect of topiramate in a rat model of inflammatory hyperalgesia.
    Paranos SLj; Tomić MA; Micov AM; Stepanović-Petrović RM
    Fundam Clin Pharmacol; 2013 Jun; 27(3):319-28. PubMed ID: 22136176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peltatoside Isolated from Annona crassiflora Induces Peripheral Antinociception by Activation of the Cannabinoid System.
    Oliveira CD; Veloso CC; Ferreira RC; Lage GA; Pimenta LP; Duarte ID; Romero TR; Perez AC
    Planta Med; 2017 Feb; 83(3-04):261-267. PubMed ID: 27574895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.
    Gutierrez T; Farthing JN; Zvonok AM; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Jan; 150(2):153-63. PubMed ID: 17160008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.
    Reeta Kh; Mediratta PK; Rathi N; Jain H; Chugh C; Sharma KK
    Regul Pept; 2006 Jul; 135(1-2):85-90. PubMed ID: 16712978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
    Haller VL; Cichewicz DL; Welch SP
    Eur J Pharmacol; 2006 Sep; 546(1-3):60-8. PubMed ID: 16919265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraspinal injection of Substance P attenuates allodynia and hyperalgesia in a rat model of inflammatory pain.
    Parenti C; Aricò G; Ronsisvalle G; Scoto GM
    Peptides; 2012 Apr; 34(2):412-8. PubMed ID: 22306475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible correlation between oxytocin-induced and angiotensin IV-induced anti-hyperalgesia at the spinal level in rats.
    Chow LH; Tao PL; Chen JC; Liao RM; Chang EP; Huang EY
    Peptides; 2013 Jan; 39():21-8. PubMed ID: 23142109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats.
    Richebé P; Rivalan B; Rivat C; Laulin JP; Janvier G; Maurette P; Simonnet G
    Can J Anaesth; 2009 Feb; 56(2):126-35. PubMed ID: 19247760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipyrone is locally hydrolyzed to 4-methylaminoantipyrine and its antihyperalgesic effect depends on CB
    Gonçalves Dos Santos G; Vieira WF; Vendramini PH; Bassani da Silva B; Fernandes Magalhães S; Tambeli CH; Parada CA
    Eur J Pharmacol; 2020 May; 874():173005. PubMed ID: 32057719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of nitric oxide in the inhibition of bone cancer-induced hyperalgesia through the activation of peripheral opioid receptors in mice.
    Menéndez L; Juárez L; García V; Hidalgo A; Baamonde A
    Neuropharmacology; 2007 Jul; 53(1):71-80. PubMed ID: 17543351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.